Compile Data Set for Download or QSAR
Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 10020
TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508740(US11046725, Example 16 | 5-Chloro-2-cyano-3-pyridy...)
Affinity DataKd:  6nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508751(US11046725, Example 31 | 3,4-Dichloro-6-fluoro-phe...)
Affinity DataKd:  13nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508739(US11046725, Example 15 | 5-Bromo-6-cyano-3-pyridyl...)
Affinity DataKd:  19nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508742(US11046725, Example 18 | 3,5-Dichloro-4-fluoro-phe...)
Affinity DataKd:  27nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508741(US11046725, Example 17 | 5-Chloro-6-trifluoromethy...)
Affinity DataKd:  28nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508746(US11046725, Example 23 | 5-Bromo-6-trifluoromethyl...)
Affinity DataKd:  32nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508738(US11046725, Example 14 | 5-Bromo-2-cyano-pyridine-...)
Affinity DataKd:  33nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508737(US11046725, Example 13 | 5-Chloro-6-cyano-pyridine...)
Affinity DataKd:  38nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508752(US11046725, Example 32 | 4-Chloro-N,N′-dimet...)
Affinity DataKd:  44nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508749(US11046725, Example 28 | 2-carboxy-5-chloropyridyl...)
Affinity DataKd:  46nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508744(US11046725, Example 21 | 3,5-dibromo-4-fluoropheny...)
Affinity DataKd:  50nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508753(US11046725, Example 33 | 5-Chloro-N,N′-dimet...)
Affinity DataKd:  54nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508743(US11046725, Example 20 | 3,4,5-trichlorophenyl 3-d...)
Affinity DataKd:  56nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508736(US11046725, Example 12 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  58nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508745(US11046725, Example 22 | 3-Bromo-4-cyanophenyl 3-d...)
Affinity DataKd:  63nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508733(US11046725, Example 6 | 5-Bromo-6-cyano-3-pyridyl ...)
Affinity DataKd:  68nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508750(US11046725, Example 29 | 5-Bromo-6-trifluoromethyl...)
Affinity DataKd:  69nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508747(US11046725, Example 24 | 3-Chloro-4-trifluoromethy...)
Affinity DataKd:  71nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508748(US11046725, Example 26 | 3-Chloro-4-methylphenyl 3...)
Affinity DataKd:  82nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508731(US11046725, Example 4 | 5-Bromo-2-cyano-pyridine-3...)
Affinity DataKd:  85nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508730(US11046725, Example 3 | 5-Chloro-6-cyano-pyridine-...)
Affinity DataKd:  95nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508732(US11046725, Example 5 | 5-Chloro-2-cyano-pyridine-...)
Affinity DataKd:  95nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508728(US11046725, Example 1 | 5-Bromo-6-trifluoromethyl-...)
Affinity DataKd:  110nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508729(US11046725, Example 2 | 5-Bromo-6-trifluoromethyl-...)
Affinity DataKd:  160nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508731(US11046725, Example 4 | 5-Bromo-2-cyano-pyridine-3...)
Affinity DataKd:  200nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508732(US11046725, Example 5 | 5-Chloro-2-cyano-pyridine-...)
Affinity DataKd:  220nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508733(US11046725, Example 6 | 5-Bromo-6-cyano-3-pyridyl ...)
Affinity DataKd:  250nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508728(US11046725, Example 1 | 5-Bromo-6-trifluoromethyl-...)
Affinity DataKd:  250nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508750(US11046725, Example 29 | 5-Bromo-6-trifluoromethyl...)
Affinity DataKd:  390nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508730(US11046725, Example 3 | 5-Chloro-6-cyano-pyridine-...)
Affinity DataKd:  420nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508734(US11046725, Example 7 | 3,4-Dichlorophenyl 3-[4-(2...)
Affinity DataKd:  490nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508729(US11046725, Example 2 | 5-Bromo-6-trifluoromethyl-...)
Affinity DataKd:  580nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508735(US11046725, Example 11 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  650nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508734(US11046725, Example 7 | 3,4-Dichlorophenyl 3-[4-(2...)
Affinity DataKd:  1.40E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508735(US11046725, Example 11 | 3,4-Dichlorophenyl 3-deox...)
Affinity DataKd:  1.70E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508753(US11046725, Example 33 | 5-Chloro-N,N′-dimet...)
Affinity DataKd:  1.70E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508752(US11046725, Example 32 | 4-Chloro-N,N′-dimet...)
Affinity DataKd:  2.10E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508740(US11046725, Example 16 | 5-Chloro-2-cyano-3-pyridy...)
Affinity DataKd:  2.20E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508738(US11046725, Example 14 | 5-Bromo-2-cyano-pyridine-...)
Affinity DataKd:  2.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508739(US11046725, Example 15 | 5-Bromo-6-cyano-3-pyridyl...)
Affinity DataKd:  2.80E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508741(US11046725, Example 17 | 5-Chloro-6-trifluoromethy...)
Affinity DataKd:  2.80E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508746(US11046725, Example 23 | 5-Bromo-6-trifluoromethyl...)
Affinity DataKd:  3.10E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508751(US11046725, Example 31 | 3,4-Dichloro-6-fluoro-phe...)
Affinity DataKd:  4.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508744(US11046725, Example 21 | 3,5-dibromo-4-fluoropheny...)
Affinity DataKd:  4.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508749(US11046725, Example 28 | 2-carboxy-5-chloropyridyl...)
Affinity DataKd:  5.70E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508743(US11046725, Example 20 | 3,4,5-trichlorophenyl 3-d...)
Affinity DataKd:  6.00E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508745(US11046725, Example 22 | 3-Bromo-4-cyanophenyl 3-d...)
Affinity DataKd:  6.00E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508747(US11046725, Example 24 | 3-Chloro-4-trifluoromethy...)
Affinity DataKd:  6.50E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508748(US11046725, Example 26 | 3-Chloro-4-methylphenyl 3...)
Affinity DataKd:  6.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM508737(US11046725, Example 13 | 5-Chloro-6-cyano-pyridine...)
Affinity DataKd:  8.00E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
US Patent

Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: